OncoDNA Enters a Strategic Marketing and Promotion Partnership with Zogen in Mexico

OncoDNA Enters a Strategic Marketing and Promotion Partnership with Zogen in Mexico

OncoDNA, the Cancer Theranostic Company, announced today that it has entered into a collaboration agreement with Promotora SN Zogen, a company that provides oncologic solutions in Mexico. Zogen will market and promote OncoDNA’s solutions to oncologists and their patients in Mexico. This partnership marks a new milestone in OncoDNA’s continuous expansion in Latin America.

Oncologists from Mexico will have access to the most advanced and high-tech molecular profiling program that combines liquid and solid biopsies analyses aspiring to improve the lives of patients with metastatic cancer. Patients will benefit from a personalized medicine based on today’s most comprehensive tumour profiling solution.

We’re excited to have Zogen as a partner and we are eager to join forces to help more patients. We’re impressed by Zogen’s professionalism and commitment and we are sure that having them on the ground will make a difference in metastatic cancer patients’ care and attention in Mexico”, says Fiona Demol, International Business Development Manager at OncoDNA.

“We are thrilled to incorporate OncoDNA’s NGS Tests to our oncologic solutions. We are convinced that this new offer will help our oncologists in Mexico to take better decisions and recommend the latest treatments for patients with metastatic cancer.” Says Marcel Peguero, Managing Director at ZOGEN. .

If you are a medical doctor from Mexico and you would like to discuss about a project or collaboration opportunity, please contact OncoDNA’s local coordinator, Alexia Cornejo, at: contacto@zogensn.com

Click on this link to download this press release: http://bit.ly/2sQ0DC7